annual FCF:
-$352.74M+$235.59M(+40.04%)Summary
- As of today (May 29, 2025), SRPT annual free cash flow is -$352.74 million, with the most recent change of +$235.59 million (+40.04%) on December 31, 2024.
- During the last 3 years, SRPT annual FCF has risen by +$131.23 million (+27.11%).
- SRPT annual FCF is now -1496.23% below its all-time high of $25.26 million, reached on December 31, 2020.
Performance
SRPT Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$629.33M-$683.29M(-1266.20%)Summary
- As of today (May 29, 2025), SRPT quarterly free cash flow is -$629.33 million, with the most recent change of -$683.29 million (-1266.20%) on March 1, 2025.
- Over the past year, SRPT quarterly FCF has dropped by -$344.81 million (-121.19%).
- SRPT quarterly FCF is now -201.72% below its all-time high of $618.67 million, reached on March 31, 2020.
Performance
SRPT quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$697.55M-$344.81M(-97.75%)Summary
- As of today (May 29, 2025), SRPT TTM free cash flow is -$697.55 million, with the most recent change of -$344.81 million (-97.75%) on March 1, 2025.
- Over the past year, SRPT TTM FCF has dropped by -$43.67 million (-6.68%).
- SRPT TTM FCF is now -363.15% below its all-time high of $265.07 million, reached on March 31, 2020.
Performance
SRPT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
SRPT Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.0% | -121.2% | -6.7% |
| 3 y3 years | +27.1% | -489.7% | -79.2% |
| 5 y5 years | +31.6% | -201.7% | -363.1% |
SRPT Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.0% | -1266.2% | at low | -139.8% | at low |
| 5 y | 5-year | -1496.2% | +40.0% | -201.7% | at low | -363.1% | +12.3% |
| alltime | all time | -1496.2% | +40.0% | -201.7% | at low | -363.1% | +12.3% |
SRPT Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$629.33M(-1266.2%) | -$697.55M(+97.7%) |
| Dec 2024 | -$352.74M(-40.0%) | $53.96M(-150.0%) | -$352.74M(-26.6%) |
| Sep 2024 | - | -$107.96M(+659.0%) | -$480.40M(-9.0%) |
| Jun 2024 | - | -$14.22M(-95.0%) | -$527.92M(-19.3%) |
| Mar 2024 | - | -$284.52M(+286.1%) | -$653.88M(+11.1%) |
| Dec 2023 | -$588.34M(+64.5%) | -$73.70M(-52.6%) | -$588.34M(-4.4%) |
| Sep 2023 | - | -$155.48M(+10.9%) | -$615.20M(+15.2%) |
| Jun 2023 | - | -$140.19M(-36.0%) | -$534.14M(+13.7%) |
| Mar 2023 | - | -$218.97M(+117.8%) | -$469.85M(+31.4%) |
| Dec 2022 | -$357.60M(-26.1%) | -$100.56M(+35.1%) | -$357.60M(+22.9%) |
| Sep 2022 | - | -$74.42M(-1.9%) | -$290.88M(-16.9%) |
| Jun 2022 | - | -$75.89M(-28.9%) | -$350.03M(-10.1%) |
| Mar 2022 | - | -$106.73M(+215.4%) | -$389.18M(-19.6%) |
| Dec 2021 | -$483.97M(-2015.7%) | -$33.84M(-74.7%) | -$483.97M(-25.9%) |
| Sep 2021 | - | -$133.57M(+16.1%) | -$653.27M(-16.6%) |
| Jun 2021 | - | -$115.04M(-42.9%) | -$783.19M(-1.5%) |
| Mar 2021 | - | -$201.52M(-0.8%) | -$794.93M(-3246.5%) |
| Dec 2020 | $25.26M(-104.9%) | -$203.15M(-22.9%) | $25.26M(-46.7%) |
| Sep 2020 | - | -$263.49M(+107.8%) | $47.36M(-79.8%) |
| Jun 2020 | - | -$126.77M(-120.5%) | $233.99M(-11.7%) |
| Mar 2020 | - | $618.67M(-441.7%) | $265.07M(-151.4%) |
| Dec 2019 | -$516.09M(+14.7%) | -$181.05M(+135.6%) | -$516.09M(+8.6%) |
| Sep 2019 | - | -$76.86M(-19.7%) | -$475.03M(-10.8%) |
| Jun 2019 | - | -$95.69M(-41.1%) | -$532.66M(-5.5%) |
| Mar 2019 | - | -$162.50M(+16.1%) | -$563.81M(+25.3%) |
| Dec 2018 | -$449.82M(+77.6%) | -$139.99M(+4.1%) | -$449.82M(+30.2%) |
| Sep 2018 | - | -$134.49M(+6.0%) | -$345.41M(+24.9%) |
| Jun 2018 | - | -$126.83M(+161.5%) | -$276.58M(+16.2%) |
| Mar 2018 | - | -$48.51M(+36.3%) | -$238.12M(-6.0%) |
| Dec 2017 | -$253.21M(+0.2%) | -$35.58M(-45.8%) | -$253.21M(-16.2%) |
| Sep 2017 | - | -$65.66M(-25.7%) | -$302.21M(+1.3%) |
| Jun 2017 | - | -$88.37M(+39.0%) | -$298.33M(+17.4%) |
| Mar 2017 | - | -$63.60M(-24.8%) | -$254.02M(+0.5%) |
| Dec 2016 | -$252.69M(+63.8%) | -$84.58M(+36.9%) | -$252.69M(+25.8%) |
| Sep 2016 | - | -$61.78M(+40.2%) | -$200.91M(+7.5%) |
| Jun 2016 | - | -$44.06M(-29.2%) | -$186.94M(+8.5%) |
| Mar 2016 | - | -$62.27M(+89.8%) | -$172.29M(+11.7%) |
| Dec 2015 | -$154.30M(-0.7%) | -$32.81M(-31.4%) | -$154.30M(+2.6%) |
| Sep 2015 | - | -$47.80M(+62.5%) | -$150.40M(-0.3%) |
| Jun 2015 | - | -$29.42M(-33.6%) | -$150.81M(-9.0%) |
| Mar 2015 | - | -$44.27M(+53.1%) | -$165.75M(+6.7%) |
| Dec 2014 | -$155.36M(+126.9%) | -$28.91M(-40.1%) | -$155.36M(+7.1%) |
| Sep 2014 | - | -$48.22M(+8.7%) | -$145.01M(+22.5%) |
| Jun 2014 | - | -$44.35M(+30.9%) | -$118.35M(+36.2%) |
| Mar 2014 | - | -$33.88M(+82.6%) | -$86.89M(+26.9%) |
| Dec 2013 | -$68.47M(+122.0%) | -$18.55M(-13.9%) | -$68.47M(+19.1%) |
| Sep 2013 | - | -$21.55M(+67.1%) | -$57.50M(+31.2%) |
| Jun 2013 | - | -$12.90M(-16.6%) | -$43.83M(+18.5%) |
| Mar 2013 | - | -$15.46M(+104.0%) | -$36.99M(+19.9%) |
| Dec 2012 | -$30.84M(+18.7%) | -$7.58M(-3.9%) | -$30.84M(+3.9%) |
| Sep 2012 | - | -$7.89M(+30.1%) | -$29.69M(+0.1%) |
| Jun 2012 | - | -$6.06M(-34.9%) | -$29.65M(+19.1%) |
| Mar 2012 | - | -$9.31M(+44.8%) | -$24.89M(-4.2%) |
| Dec 2011 | -$25.98M(+51.4%) | -$6.43M(-18.0%) | -$25.98M(+18.4%) |
| Sep 2011 | - | -$7.84M(+500.1%) | -$21.95M(+26.4%) |
| Jun 2011 | - | -$1.31M(-87.4%) | -$17.36M(-16.3%) |
| Mar 2011 | - | -$10.40M(+334.7%) | -$20.75M(+20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$17.16M(+59.0%) | -$2.39M(-26.6%) | -$17.16M(+2.2%) |
| Sep 2010 | - | -$3.26M(-30.5%) | -$16.79M(+7.6%) |
| Jun 2010 | - | -$4.69M(-31.1%) | -$15.60M(-0.6%) |
| Mar 2010 | - | -$6.82M(+236.8%) | -$15.70M(+45.4%) |
| Dec 2009 | -$10.79M(-20.4%) | -$2.02M(-2.1%) | -$10.79M(-7.6%) |
| Sep 2009 | - | -$2.07M(-56.8%) | -$11.68M(-16.7%) |
| Jun 2009 | - | -$4.79M(+150.7%) | -$14.02M(+31.0%) |
| Mar 2009 | - | -$1.91M(-34.3%) | -$10.70M(-21.1%) |
| Dec 2008 | -$13.56M(-49.4%) | -$2.91M(-34.0%) | -$13.56M(-25.9%) |
| Sep 2008 | - | -$4.41M(+199.1%) | -$18.30M(-4.5%) |
| Jun 2008 | - | -$1.47M(-69.1%) | -$19.17M(-24.7%) |
| Mar 2008 | - | -$4.76M(-37.7%) | -$25.47M(-5.0%) |
| Dec 2007 | -$26.80M(+21.5%) | -$7.65M(+45.0%) | -$26.80M(+9.4%) |
| Sep 2007 | - | -$5.28M(-32.1%) | -$24.50M(-3.1%) |
| Jun 2007 | - | -$7.77M(+27.3%) | -$25.29M(+11.9%) |
| Mar 2007 | - | -$6.10M(+14.2%) | -$22.59M(+2.4%) |
| Dec 2006 | -$22.07M(+36.8%) | -$5.35M(-11.9%) | -$22.07M(+0.0%) |
| Sep 2006 | - | -$6.07M(+19.4%) | -$22.07M(+28.7%) |
| Jun 2006 | - | -$5.08M(-8.9%) | -$17.15M(+0.5%) |
| Mar 2006 | - | -$5.58M(+4.4%) | -$17.07M(+5.8%) |
| Dec 2005 | -$16.14M(-35.1%) | -$5.34M(+364.7%) | -$16.14M(+11.4%) |
| Sep 2005 | - | -$1.15M(-77.0%) | -$14.48M(-25.5%) |
| Jun 2005 | - | -$5.00M(+7.5%) | -$19.43M(-10.1%) |
| Mar 2005 | - | -$4.65M(+26.0%) | -$21.62M(-13.0%) |
| Dec 2004 | -$24.85M(+30.0%) | -$3.69M(-39.5%) | -$24.85M(-4.8%) |
| Sep 2004 | - | -$6.10M(-15.1%) | -$26.10M(+10.3%) |
| Jun 2004 | - | -$7.19M(-8.8%) | -$23.67M(+19.1%) |
| Mar 2004 | - | -$7.88M(+59.5%) | -$19.87M(+3.9%) |
| Dec 2003 | -$19.12M(-17.0%) | -$4.94M(+34.6%) | -$19.12M(+2.6%) |
| Sep 2003 | - | -$3.67M(+8.4%) | -$18.63M(-4.8%) |
| Jun 2003 | - | -$3.39M(-52.5%) | -$19.56M(-21.3%) |
| Mar 2003 | - | -$7.13M(+60.2%) | -$24.84M(+7.8%) |
| Dec 2002 | -$23.04M(+35.5%) | -$4.45M(-3.3%) | -$23.04M(-4.3%) |
| Sep 2002 | - | -$4.60M(-46.9%) | -$24.08M(+3.7%) |
| Jun 2002 | - | -$8.67M(+62.9%) | -$23.22M(+25.4%) |
| Mar 2002 | - | -$5.32M(-3.0%) | -$18.51M(+8.9%) |
| Dec 2001 | -$17.00M(+71.0%) | -$5.48M(+46.7%) | -$17.00M(+12.5%) |
| Sep 2001 | - | -$3.74M(-5.8%) | -$15.11M(+12.9%) |
| Jun 2001 | - | -$3.97M(+4.2%) | -$13.38M(+9.0%) |
| Mar 2001 | - | -$3.81M(+5.9%) | -$12.28M(+23.5%) |
| Dec 2000 | -$9.94M(+27.5%) | -$3.60M(+79.2%) | -$9.94M(+19.1%) |
| Sep 2000 | - | -$2.01M(-29.9%) | -$8.34M(+1.3%) |
| Jun 2000 | - | -$2.86M(+94.2%) | -$8.24M(+8.7%) |
| Mar 2000 | - | -$1.47M(-26.3%) | -$7.57M(-2.9%) |
| Dec 1999 | -$7.80M(-13.3%) | -$2.00M(+5.3%) | -$7.80M(-3.7%) |
| Sep 1999 | - | -$1.90M(-13.6%) | -$8.10M(-6.9%) |
| Jun 1999 | - | -$2.20M(+29.4%) | -$8.70M(-1.1%) |
| Mar 1999 | - | -$1.70M(-26.1%) | -$8.80M(-2.2%) |
| Dec 1998 | -$9.00M(+172.7%) | -$2.30M(-8.0%) | -$9.00M(+12.5%) |
| Sep 1998 | - | -$2.50M(+8.7%) | -$8.00M(+23.1%) |
| Jun 1998 | - | -$2.30M(+21.1%) | -$6.50M(+38.3%) |
| Mar 1998 | - | -$1.90M(+46.2%) | -$4.70M(+42.4%) |
| Dec 1997 | -$3.30M(+94.1%) | -$1.30M(+30.0%) | -$3.30M(+65.0%) |
| Sep 1997 | - | -$1.00M(+100.0%) | -$2.00M(+100.0%) |
| Jun 1997 | - | -$500.00K(0.0%) | -$1.00M(+100.0%) |
| Mar 1997 | - | -$500.00K | -$500.00K |
| Dec 1996 | -$1.70M | - | - |
FAQ
- What is Sarepta Therapeutics annual free cash flow?
- What is the all time high annual FCF for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual FCF year-on-year change?
- What is Sarepta Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly FCF year-on-year change?
- What is Sarepta Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM FCF year-on-year change?
What is Sarepta Therapeutics annual free cash flow?
The current annual FCF of SRPT is -$352.74M
What is the all time high annual FCF for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual free cash flow is $25.26M
What is Sarepta Therapeutics annual FCF year-on-year change?
Over the past year, SRPT annual free cash flow has changed by +$235.59M (+40.04%)
What is Sarepta Therapeutics quarterly free cash flow?
The current quarterly FCF of SRPT is -$629.33M
What is the all time high quarterly FCF for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly free cash flow is $618.67M
What is Sarepta Therapeutics quarterly FCF year-on-year change?
Over the past year, SRPT quarterly free cash flow has changed by -$344.81M (-121.19%)
What is Sarepta Therapeutics TTM free cash flow?
The current TTM FCF of SRPT is -$697.55M
What is the all time high TTM FCF for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM free cash flow is $265.07M
What is Sarepta Therapeutics TTM FCF year-on-year change?
Over the past year, SRPT TTM free cash flow has changed by -$43.67M (-6.68%)